Form 4: Merck & Co. Executive Chirfi Guindo Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Chief Marketing Officer of Merck & Co., Chirfi Guindo, reports acquisition and disposal of common stock and adjustments in 401(k) holdings.
Summary
- On January 27, 2025, Chirfi Guindo, Chief Marketing Officer of Merck & Co., reported changes in beneficial ownership of the company's stock.
- Guindo acquired 28,158 shares of common stock at a price of $97.94 per share due to the satisfaction of performance criteria for performance share units granted on August 3, 2022.
- The performance shares were paid out at 169 percent of target awards, including accrued dividends over the three-year performance period ending December 31, 2024.
- Guindo also reported a disposal of shares from the Common Stock-401(k) Plan.
- Following these transactions, Guindo directly owns 69,143.918 shares and indirectly owns 54.7749 shares through the 401(k) plan, which includes shares acquired and dividends earned through January 8, 2025.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The vesting of performance shares at above target suggests good performance, but the document primarily reflects routine reporting.
Positives
- The vesting of performance share units at 169% of target suggests strong performance relative to the set goals.
Future Outlook
There is no specific future outlook provided in this document.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates activity by a top executive at Merck, a major player in the pharmaceutical industry.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 08/03/2022 | Date of grant for performance share units. |
| 12/31/2024 | End of the three-year performance period for the performance share units. |
| 01/08/2025 | Date through which shares and dividends were earned in the Merck U.S. Savings Plan. |
| 01/27/2025 | Date of the reported transaction (acquisition and disposal of shares). |
| 01/29/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.